France – Produits pharmaceutiques – Fourniture de produits radiopharmaceutiques pour le GCS Médecine nucléaire de Beauvais.
AI summary
This tender concerns the supply of radiopharmaceutical products to the GCS Nuclear Medicine of Beauvais, a healthcare consortium in France. The contract is structured as a framework agreement to ensure reliable provision of nuclear medicine agents for diagnostic and therapeutic applications.
Pharmaceutical companies or specialized distributors licensed to produce or supply radiopharmaceuticals and nuclear medicine products are eligible to bid.
Suppliers must be authorized to manufacture and distribute radiopharmaceutical products in compliance with pharmaceutical regulations. They should demonstrate capacity to meet quality standards and delivery schedules for nuclear medicine facilities.
Frequently asked questions
What is this tender about?
This tender concerns the supply of radiopharmaceutical products to the GCS Nuclear Medicine of Beauvais, a healthcare consortium in France. The contract is structured as a framework agreement to ensure reliable provision of nuclear medicine agents for diagnostic and therapeutic applications.
What are the requirements for suppliers?
Suppliers must be authorized to manufacture and distribute radiopharmaceutical products in compliance with pharmaceutical regulations. They should demonstrate capacity to meet quality standards and delivery schedules for nuclear medicine facilities.
What type of company should bid?
Pharmaceutical companies or specialized distributors licensed to produce or supply radiopharmaceuticals and nuclear medicine products are eligible to bid.
Who is the buyer?
The buyer is GCS MEDECINE NUCLEAIRE DE BEAUVAIS.
When does this tender close?
Submissions close on September 21, 2026.
What is the estimated value?
The estimated value is 0 EUR.
Le présent accord-cadre a pour objet la fourniture de produits radiopharmaceutiques pour le GCS Médecine nucléaire de Beauvais.
FDG (Fluorodesoxyglucose)
F-Choline (Fluorocholine)
F-DOPA (Fluorodopa)
F-PSMA (PSMA Fluoré)
FNa (Fluorure de sodium)
Traceurs plaques amyloïdes
Fluciclovine
- PriceVoir article 8.2 du Règlement de Consultation30%
- QualityValeur Technique : Voir article 8.2 du Règlement de consultation60%
- QualityDéveloppement durable : Voir article 8.2 du Règlement de consultation10%
- PriceVoir article 8.2 du règlement de consultation30%
- QualityValeur technique : Voir article 8.2 du règlement de consultation60%
- QualityDéveloppement durable : Voir article 8.2 du règlement de consultation10%
- QualityDéveloppement durable : Voir article 8.2 du règlement de consultation10%
Computing match…
AI document analysis
We read the tender PDFs and DOCX files and surface key requirements, deadlines, budget and red flags.
Loading…